The prevailing medical wisdom that Alzheimer's Disease has its origins in the brain has a radical and disputed rival with shocking implications for medicine's relentless efforts to forestall disease, ageing and death, according to a new review of the evidence.
Future treatments could bind to vulnerable site in viruses causing a variety of diseases...
New formula gauges 10-year risk of dying.
Sierra Leone's vice president has put himself in quarantine following the death from Ebola of...
Highlighting a potential target in the treatment of multiple sclerosis (MS) and Alzheimer’s disease, new research suggests that triggering a protein found on the surface of brain cells may help slow the progression of these and other neurological diseases.
Genetically engineered T memory stem cells (Tscm) can last more than 12 years in patients’ bodies, and can continually generate appropriate T cell armies for them, says an innovative study looking at two historic clinical trials.
Inflammation - the body's response to damaging stimuli - may have a protective effect against cardiovascular disease, according to a study published in the journal Lancet Diabetes and Endocrinology.
Study participants inhaled nicotine, yet they showed significantly different brain activity.
Researchers have designed a molecule that, if developed into a drug, could slow the progression of Parkinson's Disease.
Optical features embedded in marine shells may help develop responsive, transparent displays.
Researchers can precisely control the distribution of liquids suspended within each other.
A doctor who contracted the deadly Ebola virus and rode the subway system and dined out before he developed symptoms said the media and politicians could have done a better job by educating people on the science of it instead of focusing on their fears.
Scientists have used graphene to target and neutralize cancer stem cells while not harming other cells.
The bill granting the controversial techniques was passed Tuesday by the House of Lords, after being approved earlier this month by the House of Commons.
Researchers have identified a previously unknown process that many bacteria, including those that cause disease in humans, use to survive. Their discovery could lead to new therapies for bacterial infections like MRSA and tuberculosis that are resistant to current antibiotic treatments.
Unexpected findings have implications for anti-obesity therapies.
Neurons hum at different frequencies to tell the brain which memories it should store.
The study showed that skin biopsies can be used to detect elevated levels of abnormal proteins found in the two diseases.
Three Austrians have replaced injured hands with bionic ones that they can control using nerves and muscles transplanted into their arms from their legs.
New technologies will help the field of telemedicine drastically grow this year.
Researchers have identified a previously unknown effect of vitamin A in human embryonic development.
Transcription, the process in which genetic information from DNA is copied into RNA to produce proteins, requires many pieces coming together.
For years, parents of babies who seem likely to develop a peanut allergy have gone to extremes to keep them away from peanut-based foods.
Earth's past, present and future come together here on the northern peninsula of Antarctica, the wildest, most desolate and mysterious of its continents.
The Atlantic’s Olga Khazan wrote a new feature for the magazine examining the future of contraception.
23andMe, Inc., the leading personal genetics company, today announced that it has been granted authority by the U.S. Food and Drug Administration (FDA) to market the first direct-to-consumer genetic test under a regulatory classification for novel devices.
The World Health Organization said Friday it has approved a quick test for Ebola that will dramatically cut the time it takes to determine - with reasonable accuracy - whether someone is infected with the deadly virus.
More hospitals and doctors are starting to use data from fitness trackers and health apps to help treat patients. But they are moving cautiously. The technology has a lot of potential, but there are key challenges to work out...
Scientists are interested in using gels to deliver drugs because they can be molded into specific shapes and designed to release their payload over a specified time period. However, current versions aren’t always practical because must be implanted surgically.
- Page 1